Robert C. Schroeder's most recent trade in TNF Pharmaceuticals Inc. was a trade of 43,930 Common Stock done . Disclosure was reported to the exchange on April 16, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TNF Pharmaceuticals Inc. | Robert C. Schroeder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2021 | 43,930 | 43,930 | - | - | Common Stock | |
TNF Pharmaceuticals Inc. | Robert C. Schroeder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2021 | 43,930 | 0 | - | - | Restricted Stock Units | |
TNF Pharmaceuticals Inc. | Robert C. Schroeder | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.94 per share. | 16 Apr 2021 | 14,694 | 29,236 | - | 4.9 | 72,588 | Common Stock |